Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
McInnes, Iain B. [2 ]
Gottlieb, Alice B. [3 ]
Puig, Lluis [4 ]
Rahman, Proton [5 ]
Ritchlin, Christopher T. [6 ]
Li, Shu [7 ]
Wang, Yuhua [7 ]
Doyle, Mittie K. [7 ]
Mendelsohn, Alan M. [7 ]
机构：
[1] UCSD Sch Med, La Jolla, CA USA
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Tufts Med Ctr, Boston, MA USA
[4] Univ Autonoma Barcelona, Barcelona, Spain
[5] Mem Univ Newfoundland, St John, NF, Canada
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L4
引用
收藏
页码：4168 / 4168
页数：1
相关论文
共 50 条
  • [31] EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE: 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    Mease, P.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Kielar, D.
    Woltering, F.
    Stach, C.
    Hoepken, B.
    Arledge, T.
    van der Heijde, Desiree
    RHEUMATOLOGY, 2013, 52 : 162 - 163
  • [32] Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study
    Gibofsky, Allan
    Rodrigues, Jude
    Fiechtner, Justus
    Berger, Manuela
    Pan, Sharon
    CLINICAL THERAPEUTICS, 2007, 29 (06) : 1071 - 1085
  • [33] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Choy, EHS
    Sharp, JT
    Ory, PA
    Perdok, RJ
    Weinberg, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
  • [34] Efficacy and safety of ustekinumab in psoriatic arthritis patients with spondylitis and peripheral joint involvement: Results from 2 phase 3, multicenter, double-blind, placebo-controlled study
    Kavanaugh, Arthur
    Puig, Lluis
    Gottlieb, Alice B.
    Ritchlin, Christopher
    You, Yin
    Li, Shu
    Song, Michael
    Randazzo, Bruce
    Rahman, Proton
    McInnes, Iain B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S12 - S12
  • [35] Secukinumab Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: 52-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with Subcutaneous Loading and Maintenance Dosing
    Braun, Juergen
    Deodhar, Atul A.
    Sieper, Joachim
    Dougados, Maxime
    Porter, Brian
    Andersson, Mats
    Richards, Hanno
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [36] Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
    McInnes, Iain B.
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher
    Brodmerkel, Carrie
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan M.
    Doyle, Mittie K.
    LANCET, 2013, 382 (9894) : 780 - 789
  • [37] Vitamin E does not reduce symptoms of rheumatoid arthritis: A 24-week randomized, double-blind, placebo-controlled study.
    Boileau, N
    Blumberg, J
    Dallal, GE
    Golly, I
    Roubenoff, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S179 - S179
  • [38] Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    McInnes, I.
    Sieper, J.
    Braun, J.
    Emery, Paul
    van der Heijde, D.
    Isaacs, J.
    Dahmen, G.
    Wollenhaupt, J.
    Schulze-Koops, H.
    Gsteiger, S.
    Bertolino, A.
    Hueber, W.
    Tak, P. P.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S306 - S306
  • [39] Effect of Certolizumab Pegol On the Multiple Facets of Psoriatic Arthritis As Reported by Patients: 24 Week Patient Reported Outcome Results of a Phase 3 Double Blind Randomized Placebo-Controlled Study.
    Gladman, Dafna D.
    Fleischmann, Roy M.
    Coteur, Geoffroy
    Woltering, Franz
    Mease, Philip
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S242 - S243
  • [40] Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Gottlieb, Alice B.
    Sigurgeirsson, Bardur
    Blauvelt, Andrew
    Mpfofu, Shephard
    Martin, Ruvie
    Papavassilis, Charis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S136 - S137
12345